Literature DB >> 23793611

Development of a screening system for DNA damage and repair of potential carcinogens based on dual luciferase assay in human HepG2 cell.

Longgang Fan1, Yujie Niu, Shaohui Zhang, Lei Shi, Huicai Guo, Yi Liu, Rong Zhang.   

Abstract

At present, different methods are used for the detection of early biological effects of DNA-damaging agents in environment. Some sensitive testing methods employing DNA damage-inducing genes RNR3, RAD51, RAD54 or growth-arrested and DNA damage-inducible gene 153 (Gadd 153) are used to detect the DNA damage. The host cell reactivation (HCR) assay is a functional assay that is based on the independent transfection of cells with either damaged or undamaged plasmid DNA and allows the identification of the genes responsible for DNA repair-deficient syndromes. In this study, we combined the gadd153-luc test system and HCR assay to measure the DNA damage and DNA repair by dual luciferase assay. We used 16 DNA-damaging agents all of which were detected by a positive dual luciferase reporter test system. The sensitivity of the dual luciferase assay system to detect DNA damage/repair was same as the gadd153-luc test system and/or the HCR assay. Since DNA repair is important to maintain genetic stability, DNA damage and repair have been good biomarkers of early biological effects of DNA-damaging agents. Accordingly, the measurement of DNA repair capacity should be a valued tool in molecular epidemiology studies. The dual luciferase assay described in this study is rapid, convenient, stable and standard.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23793611     DOI: 10.1093/mutage/get028

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  1 in total

1.  Genetic similarity of biological samples to counter bio-hacking of DNA-sequencing functionality.

Authors:  Mohd Siblee Islam; Stepan Ivanov; Eric Robson; Tríona Dooley-Cullinane; Lee Coffey; Kevin Doolin; Sasitharan Balasubramaniam
Journal:  Sci Rep       Date:  2019-06-18       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.